Log in

NASDAQ:MBIO - Mustang Bio Stock Price, Forecast & News

$3.85
+0.02 (+0.52 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$3.60
Now: $3.85
$3.95
50-Day Range
$2.58
MA: $2.91
$3.86
52-Week Range
$2.18
Now: $3.85
$10.20
Volume897,707 shs
Average Volume459,108 shs
Market Capitalization$156.17 million
P/E RatioN/A
Dividend YieldN/A
Beta2.16
Mustang Bio, Inc, a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MBIO
CUSIPN/A
Phone781-652-4500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.32 per share

Profitability

Net Income$-30,660,000.00

Miscellaneous

Employees38
Market Cap$156.17 million
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable

Receive MBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter.


Mustang Bio (NASDAQ:MBIO) Frequently Asked Questions

What is Mustang Bio's stock symbol?

Mustang Bio trades on the NASDAQ under the ticker symbol "MBIO."

How were Mustang Bio's earnings last quarter?

Mustang Bio Inc (NASDAQ:MBIO) posted its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.25) EPS for the quarter, beating the Zacks' consensus estimate of ($0.26) by $0.01. View Mustang Bio's Earnings History.

When is Mustang Bio's next earnings date?

Mustang Bio is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Mustang Bio.

What price target have analysts set for MBIO?

3 analysts have issued 12-month price objectives for Mustang Bio's shares. Their forecasts range from $7.00 to $18.00. On average, they anticipate Mustang Bio's stock price to reach $10.67 in the next twelve months. This suggests a possible upside of 177.1% from the stock's current price. View Analyst Price Targets for Mustang Bio.

What is the consensus analysts' recommendation for Mustang Bio?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mustang Bio in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mustang Bio.

Has Mustang Bio been receiving favorable news coverage?

News stories about MBIO stock have been trending extremely negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mustang Bio earned a coverage optimism score of -4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Mustang Bio.

Are investors shorting Mustang Bio?

Mustang Bio saw a decline in short interest during the month of November. As of November 15th, there was short interest totalling 508,900 shares, a decline of 48.4% from the October 31st total of 987,100 shares. Based on an average daily trading volume, of 301,600 shares, the days-to-cover ratio is presently 1.7 days. Currently, 1.9% of the shares of the stock are sold short. View Mustang Bio's Current Options Chain.

Who are some of Mustang Bio's key competitors?

What other stocks do shareholders of Mustang Bio own?

Who are Mustang Bio's key executives?

Mustang Bio's management team includes the folowing people:
  • Mr. Michael S. Weiss, Exec. Chairman (Age 53)
  • Dr. Manuel Litchman, Pres, CEO & Director (Age 65)
  • Mr. David Jay Horin CPA, Interim Chief Financial Officer (Age 51)
  • Mr. Brian K. Achenbach, VP of Fin. & Corp. Controller (Age 54)
  • Dr. Knut Niss, Chief Technology Officer

Who are Mustang Bio's major shareholders?

Mustang Bio's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (1.18%), FNY Investment Advisers LLC (0.25%), Millennium Management LLC (0.07%), Barclays PLC (0.03%) and Tower Research Capital LLC TRC (0.02%). View Institutional Ownership Trends for Mustang Bio.

Which institutional investors are selling Mustang Bio stock?

MBIO stock was sold by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC and Barclays PLC. View Insider Buying and Selling for Mustang Bio.

Which institutional investors are buying Mustang Bio stock?

MBIO stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Millennium Management LLC and Tower Research Capital LLC TRC. View Insider Buying and Selling for Mustang Bio.

How do I buy shares of Mustang Bio?

Shares of MBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Mustang Bio's stock price today?

One share of MBIO stock can currently be purchased for approximately $3.85.

How big of a company is Mustang Bio?

Mustang Bio has a market capitalization of $156.17 million. The company earns $-30,660,000.00 in net income (profit) each year or ($1.14) on an earnings per share basis. Mustang Bio employs 38 workers across the globe.View Additional Information About Mustang Bio.

What is Mustang Bio's official website?

The official website for Mustang Bio is http://www.mustangbio.com/.

How can I contact Mustang Bio?

Mustang Bio's mailing address is 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 781-652-4500 or via email at [email protected]


MarketBeat Community Rating for Mustang Bio (NASDAQ MBIO)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  120 (Vote Outperform)
Underperform Votes:  135 (Vote Underperform)
Total Votes:  255
MarketBeat's community ratings are surveys of what our community members think about Mustang Bio and other stocks. Vote "Outperform" if you believe MBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel